98 related articles for article (PubMed ID: 16820899)
1. Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers.
Ota H; Nagano H; Doki Y; Sekimoto M; Kondo M; Wada H; Nakamura M; Noda T; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshita K; Nakamori S; Wakasa K; Sakon M; Monden M
Oncol Rep; 2006 Aug; 16(2):249-55. PubMed ID: 16820899
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules.
Nagano H; Miyamoto A; Wada H; Ota H; Marubashi S; Takeda Y; Dono K; Umeshita K; Sakon M; Monden M
Cancer; 2007 Dec; 110(11):2493-501. PubMed ID: 17941012
[TBL] [Abstract][Full Text] [Related]
3. Initial expression of interferon alpha receptor 2 (IFNAR2) on CD34-positive cells and its down-regulation correlate with clinical response to interferon therapy in chronic myelogenous leukemia.
Ito K; Tanaka H; Ito T; Sultana TA; Kyo T; Imanaka F; Ohmoto Y; Kimura A
Eur J Haematol; 2004 Sep; 73(3):191-205. PubMed ID: 15287917
[TBL] [Abstract][Full Text] [Related]
4. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha.
Oie S; Ono M; Yano H; Maruyama Y; Terada T; Yamada Y; Ueno T; Kojiro M; Hirano K; Kuwano M
Int J Oncol; 2006 Dec; 29(6):1469-78. PubMed ID: 17088986
[TBL] [Abstract][Full Text] [Related]
5. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
[TBL] [Abstract][Full Text] [Related]
6. The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFNalpha on pleomorphic sarcoma cells.
Gazziola C; Cordani N; Carta S; De Lorenzo E; Colombatti A; Perris R
Int J Oncol; 2005 Jan; 26(1):129-40. PubMed ID: 15586233
[TBL] [Abstract][Full Text] [Related]
7. [Expression of IFN-alpha/beta receptor in the PBMCs and liver of patients with hepatitis B and its clinical significance].
Fan HB; Guo YB; Wang BJ; Zhu YF; Wu AH; Hou JL; Yang DL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):979-81. PubMed ID: 18583243
[TBL] [Abstract][Full Text] [Related]
8. Type-I interferon receptor expression: its circadian rhythm and downregulation after interferon-alpha administration in peripheral blood cells from renal cancer patients.
Shiba M; Nonomura N; Nakai Y; Nakayama M; Takayama H; Inoue H; Tsujimura A; Nishimura K; Okuyama A
Int J Urol; 2009 Apr; 16(4):356-9. PubMed ID: 19302507
[TBL] [Abstract][Full Text] [Related]
9. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J; Schreiber G
J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.
Arduini RM; Strauch KL; Runkel LA; Carlson MM; Hronowski X; Foley SF; Young CN; Cheng W; Hochman PS; Baker DP
Protein Sci; 1999 Sep; 8(9):1867-77. PubMed ID: 10493588
[TBL] [Abstract][Full Text] [Related]
11. Free interferon-alpha/beta receptors in the circulation of patients with adenocarcinoma.
Ambrus JL; Dembinski W; Ambrus JL; Sykes DE; Akhter S; Kulaylat MN; Islam A; Chadha KC
Cancer; 2003 Dec; 98(12):2730-3. PubMed ID: 14669296
[TBL] [Abstract][Full Text] [Related]
12. [Type I IFN receptor].
Hino K; Yamaguchi Y; Okita K
Nihon Rinsho; 2001 Jul; 59(7):1351-5. PubMed ID: 11494550
[TBL] [Abstract][Full Text] [Related]
13. Functional expression of human type I interferon receptors in the mouse liver.
Tochizawa S; Muraguchi M; Ohmoto Y; Oga K; Mori T
Biochem Biophys Res Commun; 2006 Jul; 346(1):61-6. PubMed ID: 16750512
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha.
Esuvaranathan K; Chiong E; Thamboo TP; Chan YH; Kamaraj R; Mahendran R; Teh M
Cancer; 2007 Mar; 109(6):1097-105. PubMed ID: 17311305
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression.
Ota H; Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Nakamura M; Damdinsuren B; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Wakasa K; Monden M
Br J Cancer; 2005 Sep; 93(5):557-64. PubMed ID: 16106266
[TBL] [Abstract][Full Text] [Related]
16. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M
Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255
[TBL] [Abstract][Full Text] [Related]
17. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers.
Lamken P; Lata S; Gavutis M; Piehler J
J Mol Biol; 2004 Jul; 341(1):303-18. PubMed ID: 15312780
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of the type I interferon receptor in human fetal, adult, and neoplastic tissues.
Navarro S; Colamonici OR; Llombart-Bosch A
Mod Pathol; 1996 Feb; 9(2):150-6. PubMed ID: 8657722
[TBL] [Abstract][Full Text] [Related]
19. A flow cytometric method for determination of the interferon receptor IFNAR2 subunit in peripheral blood leukocyte subsets.
Tochizawa S; Akamatsu S; Sugiyama Y; Muraguchi M; Ohmoto Y; Ono Y; Ishikawa H; Tanigami A; Sumida T; Mori T
J Pharmacol Toxicol Methods; 2004; 50(1):59-66. PubMed ID: 15233969
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
